文献速递细菌感染、耐药与抗菌药物医院感染防控

扩展VA医院MRSA预防计划的经济学评价:纳入其他病原体感染预防

Expanding an Economic Evaluation of the Veterans Affairs (VA) Methicillin-resistant Staphylococcus aureus (MRSA) Prevention Initiative to Include Prevention of Infections From Other Pathogens.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究构建经济模型,评估美国退伍军人事务部(VA)2007年启动的全国MRSA预防计划在2008-2015财年对MRSA、医院起病革兰阴性杆菌(GNR)菌血症、耐万古霉素肠球菌(VRE)和艰难梭菌感染的成本效果与预算影响。

要点

  • VA的MRSA预防计划可能同时减少了MRSA、HO-GNR菌血症、VRE和艰难梭菌感染。

核心结论

  • VA的MRSA监测与预防策略可能预防了大量MRSA及其他病原体感染。
  • 考虑所有类型病原体感染后,实施该策略的净成本增加很小。
  • 纳入病原体特异性预防对其他病原体的溢出效应可更全面评价干预的成本与效益。

研究设计与样本

  • 模型输入包括归因成本与死亡率估计,以及通过微观成本法获得的干预成本。
  • 研究探索了若未实施该计划感染率的不同假设,效果以获得的生命年衡量。

主要发现

  • 2008-2015财年,该计划估计减少4761-9236例MRSA医院获得性感染。
  • 同期估计减少1447-2159例HO-GNR菌血症、3083-3602例艰难梭菌感染和2075-5393例VRE感染。

临床怎么用

  • 在评估MRSA预防计划的经济性时,应同时考虑其对其他病原体感染的溢出预防效益。
  • 该分析可为VA及其他医疗机构优化感染预防资源配置提供经济学参考。

局限性

  • 研究基于模型假设,未实施计划时的感染率存在不确定性。
  • 成本效果结果依赖于归因成本、死亡率和干预成本的估计值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In October 2007, Veterans Affairs (VA) launched a nationwide effort to reduce methicillin-resistant Staphylococcus aureus (MRSA) transmission called the National MRSA Prevention Initiative. Although the initiative focused on MRSA, recent evidence suggests that it also led to a significant decrease in hospital-onset (HO) gram-negative rod (GNR) bacteremia, vancomycin-resistant Enterococci (VRE), and Clostridioides difficile infections. The objective of this analysis was to evaluate the cost-effectiveness and the budget impact of the initiative taking into account MRSA, GNR, VRE, and C. difficile infections. METHODS: We developed an economic model using published data on the rate of MRSA hospital-acquired infections (HAIs) and HO-GNR bacteremia in the VA from October 2007 to September 2015, estimates of the attributable cost and mortality of these infections, and the costs associated with the intervention obtained through a microcosting approach. We explored several different assumptions for the rate of infections that would have occurred if the initiative had not been implemented. Effectiveness was measured in life-years (LYs) gained. RESULTS: We found that during fiscal years 2008-2015, the initiative resulted in an estimated 4761-9236 fewer MRSA HAIs, 1447-2159 fewer HO-GNR bacteremia, 3083-3602 fewer C. difficile infections, and 2075-5393 fewer VRE infections. The initiative itself was estimated to cost $561 million over this 8-year period, whereas the cost savings from prevented MRSA HAIs ranged from $165 to $315 million and from prevented HO-GNR bacteremia, CRE and C. difficile infections ranged from $174 to $200 million. The incremental cost-effectiveness of the initiative ranged from $12 146 to $38 673/LY when just including MRSA HAIs and from $1354 to $4369/LY when including the additional pathogens. The overall impact on the VA's budget ranged from $67 to$195 million. CONCLUSIONS: An MRSA surveillance and prevention strategy in VA may have prevented a substantial number of infections from MRSA and other organisms. The net increase in cost from implementing this strategy was quite small when considering infections from all types of organisms. Including spillover effects of organism-specific prevention efforts onto other organisms can provide a more comprehensive evaluation of the costs and benefits of these interventions.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Nelson RE, Goto M, Samore MH, et al. Expanding an Economic Evaluation of the Veterans Affairs (VA) Methicillin-resistant Staphylococcus aureus (MRSA) Prevention Initiative to Include Prevention of Infections From Other Pathogens. Clin Infect Dis. 2021. PMID: 33512526. doi:10.1093/cid/ciaa1591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。